Compare GSK plc (GSK) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs United Microelectronics Corp — how do they compare? GSK plc trades at $52.77 (market cap $101.34B), while United Microelectronics Corp trades at $22.34 (market cap $65.12B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | UMC | |
|---|---|---|
Market Cap | $101.34B | $65.12B |
Sector | Health | Technology |
52-Week High | $61.18 | $28.02 |
52-Week Low | $36.20 | $6.58 |
Enterprise Value | $121.95B | $62.70B |
Dividend Yield | 3.49% | 1.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
UMC trades at $22.26, down 6.63% over the past day, with a bullish technical signal driven by moving averages and positive momentum indicators. The company reported Q1 2026 EPS of $0.20, beating expectations, and maintains strong profitability with a 20.25% net income margin. Recent news highlights mass production milestones in silicon photonics and 14nm eHV FinFET platform advancements, supporting growth in AI and automotive demand.
Outlook remains positive with solid revenue growth and margin stability, though valuation ratios like P/E of 40.46 suggest premium pricing. Risks include competitive pressures and cyclical semiconductor demand. Analyst consensus is mixed with 26.7% buy ratings, indicating cautious optimism amid high expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
